A predictive signature for therapy assignment and risk assessment in prostate cancer

Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonci, Désirée, De Maria, Ruggero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675789/
https://www.ncbi.nlm.nih.gov/pubmed/26697526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675789/
https://www.ncbi.nlm.nih.gov/pubmed/26697526

Ejemplares similares